通报号: G/TBT/N/KOR/615 |
ICS号: 11.120.10
|
发布日期: 2015-11-13
|
截至日期: 2016-01-12
|
通报成员: 韩国
|
目标和理由: 产品或技术安全要求
|
内容概述: 关于准药品再评估,本法规提案规定了须再评估的产品选择程序、申请程序、数据提交范围、再评估结果预先通报和后续措施、反对意见的提交及最终结果通报。
|
正文:
世界贸易组织 |
G/TBT/N/KOR/615
2015-11-13
15-6029
|
|
技术性贸易壁垒 |
原文:英语
|
通 报
以下通报根据TBT协定第10.6条分发
1. |
通报成员: 韩国
如可能,列出涉及的地方政府名称 ( 3.2条和7.2 条):
|
2. |
负责机构:韩国食品药品安全部(MFDS)
|
3. |
通报依据条款:
[ ] 2.9.2
[ ] 2.10.1
[X] 5.6.2
[ ] 5.7.1
通报依据的条款其他:
|
4. |
覆盖的产品: 准药品
HS编码:30 ICS编码:11.120.10
|
5. |
通报标题: “准药品再评估程序法规”提案(8页,韩国语)
语言:韩国语 页数:8 链接网址:
|
6. |
内容简述: 关于准药品再评估,本法规提案规定了须再评估的产品选择程序、申请程序、数据提交范围、再评估结果预先通报和后续措施、反对意见的提交及最终结果通报。
|
7. |
目标与理由:保持此前批准和通报的准药品的安全和功效,加强准药品安全管理。
|
8. |
相关文件: 韩国食品药品安全部(MFDS)公告No.2015-353(2015年11月9日)
|
9. |
拟批准日期:待定
拟生效日期:待定
|
10. |
意见反馈截止日期: 通报之后60天
|
11. |
文本可从以下机构得到:
[ ] 国家通报机构
[ ] 国家咨询点,或其他机构的联系地址、传真及电子邮件地址(如能提供):
|
|
正文(英):
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6
1.
|
Notifying Member: Republic of Korea
If applicable, name of local government involved (Article 3.2 and 7.2):
|
2.
|
Agency responsible: Ministry of Food and Drug Safety
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:
International Cooperation Office
Ministry of Food and Drug Safety
187 Osongsaengmyeong2-ro, Osong-eup
Heungdoek-gu Cheongju-si
Chungcheogbuk-do, 363-700
Republic of Korea
Tel: (+82) 43 719 1564
Fax: (+82) 43 719 1550
|
3.
|
Notified under Article 2.9.2 [ ], 2.10.1 [ ], 5.6.2 [X], 5.7.1 [ ], other:
|
4.
|
Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Quasi-drugs
|
5.
|
Title, number of pages and language(s) of the notified document: Proposed "Regulation on Quasi-Drug Re-Evaluation Procedures" (8 pages, in Korean)
|
6.
|
Description of content: With regard to the re-evaluation of quasi-drugs, this proposed regulation establishes the procedures for the selection of products subject to re-evaluation, application process, scope of data submission, pre-notification of the re-evaluation results and follow-up measures, submission of objections, and notification of final results.
|
7.
|
Objective and rationale, including the nature of urgent problems where applicable: Maintain safety and efficacy of previously approved and notified quasi-drugs and enforce quasi-drug safety management
|
8.
|
Relevant documents: MFDS Notification No. 2015-353 (9 November 2015)
|
9.
|
Proposed date of adoption: To be determined
Proposed date of entry into force: To be determined
|
10.
|
Final date for comments: 60 days from notification
|
11.
|
Texts available from: National enquiry point [ ] or address, telephone and fax numbers and email and website addresses, if available, of other body:
Technical Barriers to Trade(TBT) Division
Korean Agency for Technology and Standards (KATS)
93, Isu-ro, Maengdong-myeon, Eumseong-gun
Chungcheongbuk-do
Republic of Korea 369-811
Tel: (+82) 43 870 5525
Fax: (+82 43 870 5682
E-mail: tbt@kats.go.kr
Website : http://www.knowtbt.kr
https://members.wto.org/crnattachments/2015/TBT/KOR/15_4565_00_x.pdf
|
|
|
|
|
|
|
本网维权及免责声明:
①凡本网所有原始/编译文章及图片、图表的版权均属江苏省技术性贸易措施信息平台(www.tbtguide.com)所有,如要转载,需注明"信息来源:江苏省技术性贸易措施信息平台"或"信息来源:tbtguide"。违反上述规定者,本网将保留追究其侵权责任的权利。
②凡本网注明"信息来源:XXX(非tbtguide)"的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
联系E-mail:js_wto@163.com |